BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30178840)

  • 1. Serum miR-629 is a novel molecular marker for diagnosis and the prognosis of pancreatic cancer.
    Shi W; Lu Y; Gong R; Sun JJ; Liu G
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5187-5193. PubMed ID: 30178840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
    Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
    Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
    Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B; Liu X; Gao Y; Li L; Dong Z
    Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma.
    Cai H; Zhao H; Tang J; Wu H
    J Surg Res; 2015 Apr; 194(2):505-510. PubMed ID: 25498513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance.
    Jia F; Liu M; Li X; Zhang F; Yue S; Liu J
    World J Surg Oncol; 2019 Sep; 17(1):163. PubMed ID: 31526392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer.
    Chen Q; Yang L; Xiao Y; Zhu J; Li Z
    Med Oncol; 2014 Nov; 31(11):225. PubMed ID: 25326859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
    Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
    Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.
    Tan HY; Zheng YB; Liu J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8657-8663. PubMed ID: 30575906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
    Pang PC; Shi XY; Huang WL; Sun K
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3765-3769. PubMed ID: 27735043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma.
    Wang T; Ji F; Dai Z; Xie Y; Yuan D
    Cancer Biomark; 2015; 15(5):543-50. PubMed ID: 26406942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer.
    Pang L; Zhang N; Xia Y; Wang D; Wang G; Meng X
    Oncotarget; 2016 Nov; 7(47):77854-77864. PubMed ID: 27788483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
    Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.